Healthcare

Globus Medical, Inc.(GMED)

Live Price

Offline

$84.65

+3.08% today

1Y Change

+44.45%

Window

Jun 27, 2025 → Jun 25, 2026

Market Cap: $12.17B
Revenue Growth: +16.7%
EPS Growth: +423.7%
Dividend Yield: 0.0%

Coverage: 250 bars · Jun 27, 2025 → Jun 25, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Globus Medical, Inc. (GMED) is a Healthcare stock with a market cap of $12.17B and listed on NYSE. The stock last traded around $84.65 and up 44.5% across the available one-year price window (Jun 27, 2025 → Jun 25, 2026). Baseline metrics include revenue growth of +16.7%, EPS growth of +423.7%, a dividend yield of 0.0%. What stands out right now is revenue +16.7%, EPS +423.7%, free cash flow +45.3% with operating margin 16.3% and ROIC 8.8%. Valuation sits in the middle of the pack at P/E 22.6 and price/sales 4.1. Stock Foundry combines GMED price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

GMED vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

GMED

—

Normalized return

SPY

S&P 500

Excess Return

Relative to SPY

GMED Max Drawdown

-22.10%

Trailing 1Y

SPY Max Drawdown

—

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for GMED and SPY.

Calendar-year return history is still loading or unavailable.

Unable to load analyst forecasts.

Timed out loading forecasts for GMED

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.

Read the analyst forecasts guide Compare stocks with this setup